Floatz logo

Pregabalin

Fibromyalgia

Yung Shin Pharm. Ind. Co., Ltd.Small moleculePhase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Fibromyalgia cohort.

Asset / SponsorPhaseRating
Duloxetine
Cukurova University
Phase 4BBB
PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-, (E)-
Taipei Veterans General Hospital, Taiwan
Phase 4BB
Lidocaine
Peking University Third Hospital
Phase 2BB
Zonisamide
University of Pittsburgh
Phase 4B
Gabapentin
Good Samaritan Regional Medical Center, Oregon
Phase 3B

View all 33 →

Same molecule, other indications

Pregabalin is also rated in:

focal epilepsyDormant
A
Indicative · Phase 4
82 / 100
View asset →
peripheral neuropathyActive
A
Indicative · Phase 4
82 / 100
View asset →
postherpetic neuralgiaActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →